Compare TOST & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOST | SNN |
|---|---|---|
| Founded | 2012 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 13.2B |
| IPO Year | 2021 | N/A |
| Metric | TOST | SNN |
|---|---|---|
| Price | $30.85 | $30.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 2 |
| Target Price | ★ $41.29 | $36.25 |
| AVG Volume (30 Days) | ★ 13.1M | 1.4M |
| Earning Date | 05-07-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 1766.67 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $6,153,000,000.00 | N/A |
| Revenue This Year | $22.69 | $8.58 |
| Revenue Next Year | $18.03 | $5.60 |
| P/E Ratio | $154.25 | ★ $64.97 |
| Revenue Growth | ★ 24.05 | N/A |
| 52 Week Low | $22.26 | $28.56 |
| 52 Week High | $49.66 | $38.79 |
| Indicator | TOST | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 69.64 | 50.40 |
| Support Level | $24.42 | $29.03 |
| Resistance Level | $37.08 | $31.06 |
| Average True Range (ATR) | 1.09 | 0.65 |
| MACD | 0.14 | 0.08 |
| Stochastic Oscillator | 85.43 | 63.53 |
Toast Inc is a cloud-based, all-in-one digital technology platform purpose-built for the restaurant community. The company provides a comprehensive platform of software-as-a-service (SaaS) products and financial technology solutions, including integrated payment processing, restaurant-grade hardware, and a broad ecosystem of third-party partners. It serves as a restaurant operating system, connecting front of house and back of house operations across service models such as dine-in, takeout, and delivery. It operates through one reportable segment consisting of its SaaS products, financial technology solutions, integrated payments, hardware, and partner ecosystem.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.